30 Apr
2008

Pharmaceutical trademarks

With public health and safety issues arising from pharmaceuticals hitting the headlines daily, it is hardly surprising that these concerns have permeated the assessment of whether a new pharmaceutical trademark will cause confusion. EU pharmaceutical trademarks undergo two separate assessments on this front